Night Respite for Postpartum Mothers With SUD

Completed · Not applicable

Conditions studied: Opioid Use Disorder, Maternal Drugs Affecting Fetus, Postpartum Mood Disturbance, Sleep Disorder, Neonatal Opioid Withdrawal

In brief

This single arm pilot feasibility study will evaluate the implementation of overnight infant respite care and parenting skills to mothers with substance use disorders in the early postpartum period residing in residential substance use disorder treatment programs.

Key facts

Study ID

NCT05746507

Run by

Massachusetts General Hospital

People needed

41

Starts

2022-12-20

Expected to finish

2025-04-30

Last updated by the study team

2026-01-16

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Caring for an infant under 12 months of age.
• Being the primary caretaker for their infant.
• Having a DSM-5 diagnosis of a substance use disorder.
• Currently residing in a participating residential treatment program or private home setting
• English-speaking or Spanish-speakers with limited English proficiency

You may not qualify if…

• Having an untreated serious mental health illness.
• Having an untreated substance use disorder or existing concerns that this person is actively using substances.
• Having a history of prior violence or intimate partner violence in the home.
• Provider concern regarding instability or lack of information about home safety.
• Not actively parenting an infant under 12 months of age

Where it is running

• Entre Familia Residential Treatment Program — Mattapan, Massachusetts, United States
• New Day Residential Treatment Program — Somerville, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.